BiCNU supply shortage
Executive Summary
Bristol-Myers Squibb is experiencing a supply outage of BiCNU (carmustine injection) chemotherapy, the drug maker reports Oct. 6. Bristol has not confirmed an availability date for the product, but says it is working to resolve the outage. The company is encouraging physicians and health care providers to use alternative treatments when possible. Supply issues due to production delays also occurred in May. BiCNU is indicated for palliative therapy in the treatment of brain tumors, multiple myeloma, Hodgkin's disease and non-Hodgkin's lymphoma...
You may also be interested in...
BiCNU supply shortage
Bristol-Myers Squibb announced Oct. 24 its supply difficulties with BiCNU (carmustine injection) are now a shortage; earlier the drug maker reported that it had a supply outage of the palliative cancer product ("1The Pink Sheet" Oct. 10, 2005, In Brief). The shortage is due to batches produced by a third-party supplier that needed additional assessment. Bristol has begun distributing a limited amount of the product...
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.